Sign in Subscribe

Potential Data Leak Hits Moderna, Merck Ahead of Cancer Vaccine Presentation

Moderna and Merck stocks dropped after reports of leaked Phase 3 results showing a 42% risk reduction for their melanoma vaccine.

Potential Data Leak Hits Moderna, Merck Ahead of Cancer Vaccine Presentation
"3D structure of a melanoma cell." Photo by National Cancer Institute on Unsplash
Already have an account? Sign in.